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CD163The porcine reproductive and respiratory syndrome virus (PRRSV) glycoprotein 4 (GP4) resembles a typical
type I membrane protein in its structure but lacks a hydrophilic tail at the C-terminus, suggesting that GP4
may be a lipid-anchored membrane protein. Using the human decay-accelerating factor (DAF; CD55), a
known glycosyl-phosphatidylinositol (GPI) lipid-anchored protein, chimeric constructs were made to substi-
tute the GPI-anchor domain of DAF with the putative lipid-anchor domain of GP4, and their membrane asso-
ciation and lipase cleavage were determined in cells. The DAF-GP4 fusion protein was transported to the
plasma membrane and was cleaved by phosphatidylinositol-speciﬁc phospholipase C (PI-PLC), indicating
that the C-terminal domain of GP4 functions as a GPI anchor. Mutational studies for residues adjacent to
the GPI modiﬁcation site and characterization of respective mutant viruses generated from infectious cDNA
clones show that the ability of GP4 for membrane association corresponded to virus viability and growth
characteristics. The residues T158 (ω−2, where ω is the GPI moiety at E160), P159 (ω−1), and M162
(ω+2) of GP4 were determined to be important for virus replication, with M162 being of particular
importance for virus infectivity. The complete removal of the peptide–anchor domain in GP4 resulted in a
complete loss of virus infectivity. The depletion of cholesterol from the plasma membrane of cells reduced
the virus production, suggesting a role of lipid rafts in PRRSV infection. Remarkably, GP4 was found to co-
localize with CD163 in the lipid rafts on the plasma membrane. Since CD163 has been reported as a cellular
receptor for PRRSV and GP4 has been shown to interact with this receptor, our data implicates an important
role of lipid rafts during entry of the virus.
© 2011 Elsevier Inc. All rights reserved.Introduction
Porcine reproductive and respiratory syndrome (PRRS) is a recent-
ly emerged viral disease and causes signiﬁcant economic losses to the
swine industry today. The etiological agent is the PRRS virus (PRRSV),
which is a member of the family Arteriviridae (Meulenberg et al., 1993,
1994; Wensvoort et al., 1991; Nelson et al., 1993) that includes other
viruses such as equine arteritis virus (EAV), lactate dehydrogenase-
elevating virus of mice (LDV), and simian hemorrhagic fever virus
(SHFV). The family Arteriviridae together with the families Coronavir-
idae and Roniviridae form the order Nidovirales (Cavanagh, 1997;
Cowley et al., 2000; González et al., 2003; Smits et al., 2003). PRRSV
contains a single-stranded positive-sense RNA genome of approxi-
mately 15 kb that encodes two large non-structural polyproteinsillinois.edu (G. Li).
rights reserved.(PP1a and PP1a/1b) in the 5′-terminal 12 kb region and 8 structural
proteins in the 3′-terminal 3 kb region: GP2 (glycoprotein 2), E
(small envelope), GP3, GP4, GP5, ORF5a, M (membrane), and N (nu-
cleocapsid) proteins in order (Firth et al., 2011; Johnson et al., 2011;
Meulenberg et al., 1993; Nelsen et al., 1999; Snijder and Meulenberg,
1998; Snijder et al., 1999;Wootton et al., 2000). While N protein asso-
ciates with the genomic RNA and makes up the viral capsid, the other
proteins are membrane-associated. Of these, GP5 and M form a
disulﬁde-linked heterodimer (Mardassi et al., 1996) that is essential
for virus infectivity (Faaberg et al., 1995; Snijder et al., 2003). The E
protein is amyristoylated protein (Du et al., 2010) and likely functions
as an ion-channel protein embedded in the viral envelope facilitating
the uncoating of virus and release of the genome into the cytoplasm
(Lee and Yoo, 2006). GP2, GP3, and GP4 are minor glycoproteins and
form a disulﬁde-linked heterotrimer essential for viral infectivity
(Wieringa et al., 2003a, 2003b). Co-expression of E, GP2, GP3, and
GP4 results in the transport of these proteins from the endoplasmic re-
ticulum (ER) through the Golgi, suggesting an important role of the
19Y. Du et al. / Virology 424 (2012) 18–32hetero-multimerization for virus assembly and maturation (Wissink
et al., 2005). ORF5a is a newly identiﬁed membrane protein encoded
in the internal ORF within ORF5 with an unknown function (Firth et
al., 2011; Johnson et al., 2011).
GP4 protein is of 178 and 183 amino acids for the North American
(Type II) and European (Type I) PRRSV, respectively (Meulenberg
et al., 1995; Murtaugh et al., 1995). Amino acid sequence analysis of
GP4 reveals two distinct hydrophobic domains, one at the extreme
N-terminus at positions 1–17 and the other at the C-terminus at
165–183, which likely functions as the signal peptide and amembrane
anchor, respectively (Meulenberg et al., 1995). GP4 however has a
unique structural feature, not commonly seen in the class I-type
integral membrane protein since GP4 does not contain a cytoplasmic
tail which normally protrudes into the lumen once it associates with
the membrane. The reason(s) for the lack of the cytoplasmic tail in
GP4 is unknown.
Glycosyl-phosphatidylinositol (GPI) anchor is a C-terminal post-
translational modiﬁcation found in some eukaryotic proteins residing
in the outer leaﬂet of the cell membrane. Genes encoding
GPI-anchored proteins specify two signal sequences in the primary
translation product: an N-terminal signal sequence for ER targeting
and a C-terminal hydrophobic sequence that directs its association to
the membrane via the lipid (Orlean and Menon, 2007). The process
for GPI biosynthesis takes place in the ER (Takeda and Kinoshita,
1995), and the proteins subjected to GPI-modiﬁcation enter the ER
lumen via the N-terminal ER targeting signal which is cleaved off by a
signal peptidase in the lumen (Gerber et al., 1992). In addition to the
N-terminal signal sequence, GPI-anchored proteins contain a
C-terminal hydrophobic sequence that directs the cleavage of the signal
sequence from the protein and the replacement with a preformed GPI-
anchor by action of the transamidase complex (Ikezawa, 2002). The
GPI-linked proteins are then targeted to themembranes. The structural
feature of PRRSV GP4 resembles that of a GPI-anchored protein.
Hundreds of functionally and structurally diverse proteins have
been identiﬁed as GPI-anchored proteins including the NS1 protein
of Dengue virus (Jacobs et al., 2000), prion proteins for transmissible
spongiform encephalopathies (Taylor and Hooper, 2006), adhesion
molecules (Dustin et al., 1987), decay accelerating factor (DAF;
Nickells et al., 1994), just to name a few (see a review; Ikezawa,
2002). GPI modiﬁcation serves a variety of functions including direct-
ing proteins to the cell surface (Lisanti et al., 1988), association with
lipid rafts (Taylor and Hooper, 2006), lymphocytes activation
(Robinson et al., 1989), and signal transduction (Cary and Cooper,
2000; Jacobs et al., 2000). The GPI anchor in particular has the pro-
pensity to target proteins to lipid rafts (Brown and London, 1998;
Metzner et al., 2008). Lipid rafts are dynamic assemblies of the
lipid-ordered phase of microdomains that are highly enriched with
cholesterol and sphingolipids in the exoplasmic leaﬂet of the plasma
membrane (Ikonen, 2001; Simons and Toomre, 2000). Lipid rafts
compartmentalize cellular processes by serving as organizing centers
for assembly of signaling molecules, inﬂuencing membrane ﬂuidity
and protein trafﬁcking, endocytosis, transcytosis as well as for host–
pathogen interactions (Ikonen, 2001; Pike, 2009; Simons and
Toomre, 2000; van der Goot and Harder, 2001). For viruses, lipid
rafts play an important role in viral entry (Ewers and Helenius,
2011); Norkin, 1999; Parton and Lindsay, 1999; Vieira et al., 2010,
assembly (Manié et al., 2000; Ono and Freed, 2001) and budding
(Chazal and Gerlier, 2003; Scheiffele et al., 1999). Some viral
membrane-associated and also envelope proteins such as the Gag
protein of human immunodeﬁciency virus type 1 (HIV-1) (Ono and
Freed, 2001), the hemagglutinin of inﬂuenza virus (Takeda et al.,
2003), the tegument protein of herpes simplex virus (Lee et al.,
2003), the NS1 protein of dengue virus (Noisakran et al., 2008), and
the spike protein of severe acute respiratory syndrome coronavirus
(SARS-CoV) (Lu et al., 2008) associate with the lipid rafts. The in-
volvement of lipid rafts in PRRSV infection has not been examined.In the present study, we provide evidence that the viral GP4 protein
is a GPI-anchored protein, which co-localizes with the PRRSV recep-
tor, CD163 in the lipid rafts and may be involved in the viral entry
process.
Results
GPI-anchored membrane association of PRRSV GP4
The topology of GP4 predicts two hydrophobic domains on the
protein; one at residues 1–17 and the other at 164–178 (http://
mobyle.pasteur.fr/cgi-bin/portal.py?#forms::toppred; Claros and
von Heijne, 1994). The N-terminal hydrophobic domain likely func-
tions as the signal peptide to direct the protein to ER membrane and
the C-terminal hydrophobic domain to anchor the protein to mem-
brane, but unlike the common structure seen in type I membrane gly-
coproteins, GP4 does not possess a hydrophilic cytoplasmic tail
following the hydrophobic anchor domain at the C-terminus (Fig. 1).
The cytoplasmic tail generally protrudes into the lumen when the pro-
tein is associated with the ER membrane, and the unusual feature of
GP4 resembles the topology of GPI-anchored protein, for example,
DAF which is a well-characterized GPI-anchored protein (Nickells et
al., 1994). When GP4 sequences were analyzed using the GPI predic-
tion program (http://gpi.unibe.ch; Fankhauser and Mäser, 2005), a
GPI anchor signal was readily detectable. When a large number of
GP4 sequences were examined including the European and North
American genotypes, the European-like PRRSV circulating in the USA,
and the highly virulent PRRSV emerged in China (Fig. 1A), the GPI an-
chor signal became more prominent and appeared to be highly con-
served across the genotypes including LDV and EAV. Thus, we
hypothesized that the PRRSV GP4 protein might be modiﬁed by GPI at-
tachment and anchored with the membrane through the GPI.
Since GP4 is a minor protein and thus its expression level is low,
and because a suitable antibody for GP4 is not available, a GP4–EGFP
fusion construct was made using a linker of ﬁve glycine residues
inserted between the EGFP and GP4 sequences to facilitate the detec-
tion of GP4 in cells (Fig. 1B; Tsuneki et al., 2007). When HeLa cells
were transfected with the pEGFP-GP4 plasmid, the GP4–EGFP fusion
protein of about 56kDa was expressed (Fig. 2A, lane 4). In addition,
a minor band of 30 kDa which was slightly larger than EGFP alone
was identiﬁed (Fig. 2A, lane 4, ΔGP4), suggesting that the C-terminal
portion of GP4 might have been cleaved and the cleaved portion
which was fused with EGFP was detectable by EGFP antibody. Such
band was absent in cells transfected with pEGFP-N which is a
fusion construct of the PRRSV N protein with EGFP (Fig. 2A, lane 5).
This result suggests that GP4 is possibly a GPI-anchored protein and
not all but some of the GP4molecules aremodiﬁed by GPI attachment.
A GPI-anchored protein can be distinguished from its un-modiﬁed
form by its mobility (Ikezawa, 2002), and thus the migration pattern
of GP4 was examined by SDS-PAGE and western blot. HeLa cells
naturally express human DAF as a 41 kDa protein before GPI-
modiﬁcation (Karnauchow et al., 1996) and after glycosylation and
GPI-modiﬁcation, it becomes approximately 82–88 kDa (Nickells et
al., 1994), which can readily be detectable by DAF MAb from cell
lysates (Fig. 2B, lane 4). To facilitate the detection of GP4 while main-
taining its structural integrity as much as possible, the Flag sequence
tag of ‘YKDDDDK’ was inserted between positions D87 and E88 of
GP4, and pXJ41-FLAG-GP4 was constructed (Fig. 1C). HeLa cells trans-
fected with pXJ41-FLAG-GP4 produced the GP4 protein of approxi-
mately 29 kDa (Fig. 2B, lane 3, lower arrow). This form of GP4 was
predominant among two other forms of GP4 produced in these
cells. GP4 is an integral membrane protein with multiple glycans
added onto it (Meulenberg et al., 1995; Wissink et al., 2005), and
the 29 kDa protein and two additional bands of smaller sizes likely
represent the fully mature and the partially glycosylated forms of
GP4 as previously observed (Das et al., 2010). A 50 kDa band was
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Fig. 1. Sequence alignments of the C-terminal region of GP4 protein from various types of PRRSV and other arteriviruses (A). VR2332, PA8, MN184, Prime Pac, and RespPRRS rep-
resent North American PRRSV genotype II. BJ and HUN4 represent the highly virulent PRRSV recently emerged in China. Lelystad and EU-2a represent European PRRSV genotype I.
EuroPRRS represents the prototype European PRRSV identiﬁed in the USA. LDV, lactate dehydrogenase-elevating virus of mice; EAV, equine arteritis virus; SHFV, simian hemorrhag-
ic fever virus. GenBank accession numbers are indicated in parenthesis. Putative GPI anchor attachment (omegaω) sites are indicated in box. (B) Structural presentations of the GP4
protein of PRRSV PA8. GP4 contains two hydrophobic domains (HD), one at the N-terminus and the other at the C-terminus. GP4 was cloned to express as a fusion protein with
EGFP using a linker of ﬁve glycine (5G) residues. ‘ω’ at position 160 (E160) indicates the putative GPI modiﬁcation site, and the arrow between positions 160 and 161 indicates
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modiﬁed GPI-anchored form of GP4.
To determine the GPI modiﬁcation of GP4, phosphatidylinositol-
speciﬁc phospholipase C (PI-PLC) digestion was conducted. PI-PLC is
a lipase known to cleave and release a GPI-linked protein from the
cellular membrane, and therefore the release of a soluble protein by
PI-PLC digestion is considered standard biochemical evidence for
GPI-anchored proteins (Ikezawa, 2002). For this experiment, HEK-
293 cells were transfected with pXJ41-FLAG-GP4 and at 24 hpt, tryp-
sinized and digested with PI-PLC in suspension. The supernatants
were then analyzed by western blot using anti-FLAG Ab. In parallel,
PI-PLC-digested cells were subjected to FACS analysis after staining
with anti-FLAG Ab. Unexpectedly, no protein band equivalent to
digested GP4 was observed from the supernatants, and the intensity
of ﬂuorescence was not diminished in PI-PLC-digested cells as com-
pared to the untreated cells (data not shown). Total lysates of PI-
PLC-digested cells and untreated cells were also examined by western
blot, but no difference was found in their migration patterns. The
50 kDa band did not change its migration after PI-PLC digestion
(data not shown), and we concluded that the GPI modiﬁcation of
GP4 was resistant to PI-PLC digestion.When intact cells are treated with PI-PLC, partial or total resistance
to digestion may occur due to the inaccessibility of an enzyme to the
cleavage site, expression of the protein on the cell surface in both
GPI-modiﬁed and GPI-unmodiﬁed hydrophobic peptide-anchored
forms, or tight association of the GPI-modiﬁed protein with a PLC-
non-susceptible protein on the cell surface (Rosenberry, 1991). The
PRRSV GP4 protein may exist as the GPI-modiﬁed form and the GPI-
unmodiﬁed hydrophobic peptide-anchored form, which may have
caused the inability of PI-PLC digestion. Thus to further determine if
GP4 was a GPI-modiﬁed protein, two chimeric constructs were made
such that the known GPI-anchor domain of human DAF was substitut-
ed with the putative GPI-modiﬁcation domain of GP4 protein (Figs. 3A,
B) and the C-terminal hydrophobic region of GP2 protein of PRRSV
(Fig. 3C). The residue cross-linked to the lipid moiety is termed ω
site, and upstream residues are designated ω-minus while down-
stream residues are designated ω-plus with respect to their positions
from the ω site (Ikezawa, 2002). The ω site of human DAF is serine at
position 353 (S353) (Nickells et al., 1994; Fig. 3A), which is identical
to the computer prediction (GPI modiﬁcation prediction; http://
mendel.imp.ac.at/gpi/gpi_server.html). By using the same program,
the potential ω site for GP4 was predicted to be at E160, and based
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Fig. 2. Expression and detection of GP4 in HeLa cells. (A) Cells were transfected with pEGFP-GP4 for 24 h (lane 4) and the total cell lysates were subjected to western-blot using anti-
GFP rabbit antibody. For GFP expression, 2.0, 1.0, 0.5 μg of pEGFP-N1 (Clontech) was individually transfected for differential expression (lanes 1, 2, and 3). pcDNA3.0 (Invitrogen)
which contains the identical promoter to that of pEGFP-N1 (Clontech) was used to make up the total DNA of 2.0 μg. The PRRSV N gene fused with EGFP (pEGFP-N; Rowland et al.,
2003) served as an additional control (lane 5) and β-actin served as the loading control. (B) Western blot of the total lysates of HeLa cells transfected with pXJ41-Flag-GP4 (lane 3).
HeLa cells were mock-transfected (lane 1) or transfected with the empty vector pXJ41 (lane 2) as controls. HeLa cells constitutively express human DAF readily detectable by anti-
DAF MAb (Sigma-Aldrich), and this protein served as a positive control of GPI-anchored DAF (lane 4).
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with the 349–381 fragment of human DAF to construct pXJ41-DAF/4
(Fig. 3B). The PRRSV GP2 protein was chosen to serve as a GPI-
negative control and the 204–256 fragment of GP2 was used to replace
the 349–381 region of DAF. This construct was designated pXJ41-DAF/
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22 Y. Du et al. / Virology 424 (2012) 18–32migration reduces to 67 kDa (Nickells et al., 1994). In our study, the
molecular migration of human DAF in HeLa cells decreased from
82–88 kDa to 65–70 kDa when digested with PI-PLC (Fig. 4A, lanes
2, 4), which was consistent with the orangutan report. After PI-PLC
digestion, ﬂuorescent cells by DAF staining were also reduced by
96% in HeLa cells (Figs. 4, Ba, Ca), conﬁrming the efﬁcient digestion
of DAF by PI-PLC. In contrast, HEK-293 cells transfected with the
empty vector pXJ41 showed no ﬂuorescence for DAF (Figs. 4, Bb,
Cb), and no cleavage product was released by PI-PLC digestion
(Fig. 4A, lane 6). Thus, HEK-293 cells were transfected with pXJ41-
DAF, pXJ41-DAF/4, or pXJ41-DAF/2, and analyzed by PI-PLC digestion
followed by western blot (Fig. 4A), ﬂuorescence staining (Fig. 4B),
and FACS (Fig. 4C) analyses. DAF/2, DAF, and DAF/4 were all
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of ﬂuorescence-positive cells were unaffected for DAF/2 by PI-PLC
treatment (Fig. 4B, panel c; Fig. 4C, panel c), and the DAF/2 protein
was not detectable in the supernatant (Fig. 4A, lane 8). These results
show that the C-terminal region of GP4 was modiﬁed for PI-PLC-
speciﬁc GPI-attachment, whereas GP2 protein did not undergo such
a modiﬁcation, which is consistent with previous reports that GP2
anchors on the cell membrane through the C-terminal hydrophobic
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Since our data showed that PRRSV GP4 was a GPI-modiﬁed pro-
tein, the importance of individual amino acids surrounding the GPI
attachment site (ω site) was examined for PI-PLC cleavage. Using
pXJ41-DAF/4 as the parental construct, six mutants were constructed
such that the residues adjacent to E160 (the ω site) were individually
changed to valine (Fig. 5A; Gerber et al., 1992; Furukawa et al., 1997).
Following expression in transfected cells and after PI-PLC digestion of
wild-type DAF/4, the cleaved product released into the supernatant
was identiﬁed as a 65–70 kDa band (Fig. 5B, lane 2). Mutants DAF/
4-M157V (ω−3) and DAF/4-E160V (ω) showed similar cleavage
properties to those of wild-type DAF/4 as inferred from the intensity
of the cleaved product (Fig. 5B, lanes 4, 10) and the percentage of
positive cells (Fig. 5C, panels a, d; Fig. 5D, panels a, d).
For DAF/4-T161V (ω+1), the ﬂuorescence intensity was 6×102
as compared to 1×103 for DAF/4 (Fig. 5C, panel e; Fig. 5D, panel e).
The release of DAF in the supernatant reduced slightly (Fig. 5B, lane
12), but the percentage of positive cells for DAF/4-T161V was similar
to that of DAF/4 (Fig. 4C, panel e; Fig. 5D, panel e). The percentage of
positive cells for DAF/4-T158V (ω−2) was signiﬁcantly lower
(Pb0.05) than those of DAF/4, followed by DAF/4-P159V (ω−1),
and DAF/4-M162V (ω+2) (Fig. 5D, panels b, c, f). Their intensity of
ﬂuorescence also decreased in order (Fig. 5C, panels b, c, f; Fig. 5D,
panels b, c, f), and DAF released to the supernatant decreased accord-
ingly (Fig.5B, lanes 6, 8, 14). DAF/4-M162*, whose the C-terminal hy-
drophobic domain was truncated by mutating M162 to the TAG stop
codon (Fig. 5A), was anticipated not to anchor the GP4 protein on the
cell membrane, and as expected no band was released in the superna-
tant of the digestion reaction (Fig. 5B, lane 16; Fig. 5C, panel g; Fig. 5D,144
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plasmids and 1 day post-transfection, were collected by trypsinization. Cells were then wa
with PI-PLC at 1.5 unit/ml (+) while the other fraction was mock-digested (−), followed
their supernatants were subjected to western blot (B), whereas pelleted cells were subje
(C) and FACS for surface expression of DAF (D) analyses using anti-DAF MAb. DIC, differenpanel g). These results show that the residues surrounding the ω site
of GP4 contribute to the ability of GPI to anchor to the membrane.
These experiments were repeated three times for conﬁrmation, and
the representative results are shown in Figs. 5C and D. In summary,
all mutations but M162* retained the ability of GPI-anchorage to var-
ious extents.
Generation of GPI-anchor mutant viruses
To determine the signiﬁcance of residues adjacent to the ω site of
GP4 for virus infectivity, the respective mutations were introduced
into the PRRSV infectious cDNA clone and a total of 7 mutant viral ge-
nomic clones were generated. The PRRSV infectious cDNA clone was
modiﬁed to place the full-length genomic sequence under the eu-
karyotic promoter and thus DNA transfection of the full-length geno-
mic clones can produce infectious progeny in transfected cells. Thus,
the wild type and mutant genomic clones were transfected into
MARC-145 cells and the cells were incubated for 5 days. Cytopathic
effects (CPE) were evident for PRRSV-GP4-WT and some of the mu-
tants. Culture supernatants were collected and designated ‘passage-
1’. For mutants that did not produce visible CPE, extracellular and in-
tracellular RNAs were examined for the presence of viral genome by
RT-PCR for N gene at passages 3 and 5. The mutant viruses PRRSV-
GP4-M157V (ω−3), PRRSV-GP4-E160V (ω), and PRRSV-GP4-T161V
(ω+1) grew to titers similar to that of PRRSV-GP4-WT (Fig. 6A),
and these were the mutants that did not impair the ability for GPI-
anchorage in HEK-293 cells. These mutant viruses grew normally
and induced CPE typical for PRRSV. Mutation at ω−2 (T158V),
ω−1 (P159V), and ω+2 (M162V) appeared to be important for
virus growth as the titers for PRRSV-GP4-T158V, PRRSV-GP4-P159V,164 178
HD
T1
61
V
M
16
2V
M
16
2*
pernatants
0 11 12 13 14 15 16
 +     -    +     -     +      -      +   PI-PLC 
65-70 kD 
line (V) using pXJ41-DAF/4 as the parental plasmid. Constructs were designated based
K-293 cells were transfected with pXJ41-DAF/4 wild-type (WT) or individual mutant
shed in PI-PLC buffer and divided into two equal fractions. One fraction was digested
by incubation at 37 °C for 30 min. Cells were centrifuged at 2000 rpm for 10 min, and
cted to immunoﬂuorescence using a ﬂuorescent microscope (model AX70, Olympus)
tial interference contrast microscopy.
C)
D)
(g)(f)(e)
(g)(f)(e)
(c)
(c)
(d)
(d)
(b)
(b)
(a)
(a)
Fig. 5 (continued).
24 Y. Du et al. / Virology 424 (2012) 18–32and PRRSV-GP4-M162V decreased in ‘passage 2’ and ‘passage 3’
(Fig. 6A). Their growth kinetics was also slower compared to that of
PRRSV-GP4-WT (Fig. 6B), and their characteristics were consistent
with their ﬂuorescence staining. In particular, PRRSV-GP4-M162V
(ω+2) appeared to affect the virus infectivity most notably. PRRSV-
GP4-M162V grew slowly and its titer was also low. The truncation
mutant PRRSV-GP4-M162* did not exhibit any sign of infectivity
(Figs. 6A, B). Furthermore, no viral RNA was detectable at passages
3 and 5 and thus it was concluded that the lack of GPI-anchor, thus
the lack of membrane association, was lethal for PRRSV infectivity.Inhibition of virus entry by cholesterol depletion in MARC-145 and PAM
cells
For mouse hepatitis coronavirus, a member virus in the Order Nido-
virales, the cholesterol levels on the cell membrane determine the sus-
ceptibility of cells to virus infection, and lipid rafts are required for virus
entry and membrane fusion (Choi et al., 2005). Since cholesterol is a
major component residing in the lipid rafts of the cell membrane, we
examined whether lipid rafts were involved in the entry of PRRSV in
permissive cells. A cholesterol-depletion experiment was conducted
Fig. 6. Production of ‘passage-2 (P2)’ and ‘passage-3 (P3)’ mutant viruses in MARC-145
cells (A) and their growth kinetics (B).FreshMARC-145 cellswere infectedwith ‘passage-2’
virus at a multiplicity of infection (MOI) of 5, and their supernatants were harvested at in-
dicated times. Virus titers were determined by a microtitration infectivity assay and
recorded as tissue culture infectious dose (TCID)50/ml. Experiments were conducted in
duplicate and repeated three times. The data are shown as mean titers±standard error.
25Y. Du et al. / Virology 424 (2012) 18–32using methyl-β-cyclodextrin (MβCD) in both MARC-145 and PAM
cells. MβCD is not incorporated into membranes but extracts cholester-
ol selectively from membranes by binding it in the central non-polar
cavity and thus depleting from the plasma membrane (Ilangumaran
and Hoessli, 1998). To avoid the possibility that the newly synthesized
cholesterol and/or cholesterol from internal compartments may re-
store the rafts and affect the entry of virus, incubation of MβCD-
treated cells with PRRSV was limited to 1 h at 37 °C. It was apparent
that the MβCD treatments of MARC-145 and PAM cells impaired the
production of PRRSV in a dose-dependent manner (Figs. 7A, B),
suggesting an essential role of cholesterol for PRRSV entry.
To conﬁrm the involvement of cholesterol in PRRSV infectivity, a
depletion reversion study was conducted. Cells were treated with
MβCD for 1 h and then, the depletion was reversed by supplementing
with cholesterol at various concentrations, followed by PRRSV
infection and examination of virus yield from these cells. After replen-
ishment with cholesterol, the virus titer increased dramatically, and
at 100 μg/ml of cholesterol supplementation, the production of virus
was almost fully restored in both MARC-145 and PAM cells
(Figs. 7C, D).These data indicate that the reduction of virus produc-
tion by MβCD was due to the depletion of cholesterol from the cells
and this effect was reversible, suggesting a role of lipid rafts in
PRRSV infection.GP4 localizes to lipid rafts
The importance of cholesterol for PRRSV infection suggests that
viral proteins may interact with cellular proteins in the lipid rafts dur-
ing entry. GPI modiﬁcation has the propensity to target the GPI-
proteins to lipid rafts (Brown and London, 1998) and since PRRSV
GP4 is a GPI-anchored protein, its localization in the lipid rafts was
ﬁrst examined by dual staining immunoﬂuorescence. DAF (a syno-
nym of CD55) is a resident protein in the lipid rafts and thus is
frequently used as a marker for lipid rafts (Stuart et al., 2002). Since
HeLa cells constitutively express DAF which is readily detectable by
DAF-speciﬁc MAb EVR1 (Fig. 2B, lane 4; Fig. 8A), HeLa cells were used
to examine co-localization of GP4 and DAF proteins. The GP4 protein
fused with a Flag-tag was detectable on the cell membrane (Figs. 8E,
H) and was co-localized with CD55 (Figs. 8F, I), demonstrating that
the PRRSV GP4 protein is a membrane protein localized in the lipid
rafts in HeLa cells.
Co-localization of GP4 with CD163 in the lipid rafts
CD163 has been studied as a cellular receptor for PRRSV, and
CD163 renders PRRSV non-permissive cells permissive for infection
(Calvert et al., 2007; Lee et al., 2010; Patton et al., 2009). CD163 has
been shown to localize and form high partition in the lipid rafts
(Wolf et al., 2007). Since GP4 co-localizes with DAF (Fig. 8), co-
localization of GP4 with CD163 was examined. For this study, cells
of the porcine origin were used to co-express both GP4 and CD163.
Dulac cells are porcine kidney cells but non-permissive for PRRSV in-
fection, and thus using these cells, a cell line was generated to stably
express porcine CD163 which was then designated Dulac-CD163.
Dulac-CD163 cells were RT-PCR positive for CD163 transcription
(Fig. 9A, lane 4) and the protein was also expressed (Figs. 9B, C).
Dulac-CD163 cells became permissive for PRRSV infection and the
GFP expression was evident when infected with PRRSV-P129-GFP
virus (Fig. 9D), conﬁrming the expression of porcine CD163 and infec-
tion of PRRSV in these cells. When Dulac-CD163 cells were transfected
with pXJ41-Flag-GP4, CD163 and GP4 were found to be co-localized
on the plasma membrane (Figs. 10, F, I). These results demonstrate
the interaction of GP4 with CD163 in the lipid rafts and suggest that
this interaction may participate in the initial stage of virus entry into
cells.
Discussion
The signal for GPI modiﬁcation of a protein consists of three parts:
a stretch of three amino acids including the residue where GPI
attaches (the ω site), a hydrophobic segment of 12–20 amino acids,
and a hydrophilic spacer segment of usually less than 10 amino
acids between them (Furukawa et al., 1997). For modiﬁcation, the hy-
drophobic segment is ﬁrst cleaved and the lipid is then attached
(Gerber et al., 1992). The GP4 protein satisﬁes the above conditions
with a hydrophobic segment of 15 residues at the C-terminus and a
hydrophilic space of 3 amino acids between the hydrophobic segment
and the ω site (Fig. 1A). In the present study, we provide evidence
that the PRRSV GP4 protein can undergo post-translational modiﬁca-
tion for GPI attachment and anchors to the membrane via the lipid.
The GP4–EGFP fusion protein was cleaved at the ω site and the
30 kDa peptide was likely the cleavage product representing the
C-terminal portion of GP4 fused with EGFP. GP4 existed in two forms
to anchor to the membrane, and this observation was consistent with
other lipid-anchored proteins such as LFA-3 (lymphocyte function-
associated antigen 3) and NCAM-1 (neural cell adhesion molecule
1) as they also exist in two forms, a hydrophobic peptide-anchored
form and a lipid-anchored form (Arai et al., 2004; Cross, 1990; Dustin
et al., 1987). These alternative forms behave differently. The routes
(Rothberg et al., 1990) and rates (Keller et al., 1992) for endocytosis
Fig. 7. Reduction of virus production by MβCD in MARC-145 (A) and PAMs (B) cells. Cells were pretreated with 0.25–2.0 mM of MβCD for 1 h at 37 °C followed by infection with
PRRSV PA8 for 1 h at a MOI of 5. Supernatants were collected 3 days post-infection fromMARC-145 cells or 20 h post-infection from PAMs and subjected to virus titration in MARC-
145 cells by microtitration infectivity assays. For cholesterol replenishment assays, MARC-145 (C) or PAM (D) cells were pretreated with 2.0 mM of MβCD for 1 h at 37 °C followed
by supplementation with cholesterol at indicated concentrations for 1 h at 37 °C, and then infected with PRRSV for 1 h at a MOI of 5. Culture supernatants were collected 3 days
post-infection and titrated as described above. Experiments were conducted in duplicate and repeated three times. The data are shown as mean titers±standard error.
26 Y. Du et al. / Virology 424 (2012) 18–32of the GPI-anchored and hydrophobic peptide-anchored proteins dif-
fer. In addition to the transport differences, the lipid-anchored and
peptide-anchored forms of a same protein can also have different bio-
logical properties. The lymphocyte surface molecules Ly-6A/E and Qa-2
only activate T cells when present as a GPI-anchored form (Robinson et
al., 1989; Su et al., 1991).
The GP4 protein expressed as the Flag-GP4 fusion protein
appeared to be resistant to PI-PLC digestion, and this was likely due
to the co-existence of lipid-anchored and peptide-anchored forms of
GP4. In contrast, the DAF/4 construct became sensitive to PI-PLC di-
gestion, and constructs made in the similar way have been shown
to be useful for some proteins including CD4 for the study of HIV.
HIV efﬁciently infected human cells expressing the GPI-anchored
CD4 receptor (Diamond et al., 1990; Jasin et al., 1991) and the CD4-
GPI fusion protein was efﬁciently cleaved by PI-PLC (Anderson et al.,
1996).
Replacement of the GPI modiﬁcation signal by a hydrophobic pep-
tide segment leads to expression of the protein as a peptide-anchored
membrane protein (Takeda and Kinoshita, 1995), and this was consis-
tent with our ﬁnding that DAF/2, in which the GPI modiﬁcation signal
in DAF was substituted with the hydrophobic segment of GP2, resulted
in peptide-anchored membrane association and thus non-digestible by
PI-PLC. This ﬁnding conﬁrms that unlike GP4, GP2 is a type I integral
membrane protein (Meulenberg et al., 1995; Wissink et al., 2005). In
contrast to DAF/2, DAF/4 was successfully digested by PI-PLC, demon-
strating that the C-terminal region of GP4 indeed possessed the GPI-
modiﬁcation signal. M157V (ω−3), E160V (ω), and T161V (ω+1)
mutations of GP4 did not affect the GPI-modiﬁcation or the growth of
mutant viruses, but T158V (ω−2), P159V (ω−1), and M162V
(ω+2) were important for both GPI modiﬁcation and the virus infec-
tivity. The residues at positions ω−2, ω−1, and ω+2 were highly
conserved among different PRRSV isolates of the North American and
European genotype, and among those three mutations, M162V(ω+2) contributed the most to the GPI modiﬁcation and virus infec-
tivity. The M162* mutation, the C-terminal 16 amino acids truncation
mutant, was lethal for infectivity, indicating the essential requirement
of this hydrophobic segment for PRRSV infection. This is the ﬁrst report
that the GPI-anchor of a viral membrane protein contributes to viral
infectivity and growth rates.
For viruses to infect target cells, they ﬁrst bind to a speciﬁc
receptor on the cell surface. For PRRSV, CD163 is the cellular receptor
(Calvert et al., 2007) and has been recently shown to interact with
GP2 and GP4 proteins (Das et al., 2010). CD163 is a macrophage-
speciﬁc protein in the cysteine-rich scavenger receptor superfamily
comprising a large number of cell surface and soluble glycoproteins
involved in the recognition of various ligands of proteins, polyribonu-
cleotides, polysaccharides, and lipids (Sarrias et al., 2004). The locali-
zation of a receptor in the lipid rafts is crucial for entry of some
viruses (Ewers and Helenius, 2011) including SV40 and murine leu-
kemia virus (Lu and Silver, 2000; Pelkmans et al., 2001). For nido-
viruses, CD13 is the cellular receptor for human coronavirus 229E
and is localized in the lipid rafts (Nomura et al., 2004), and the impor-
tance of lipid rafts for virus replication has also been documented
(Lorizate and Kräusslich, 2011; Lu et al., 2008; Thorp and Gallagher,
2004). We show in the present study that GP4 localizes to the lipid
rafts of the plasma membrane where it associates with CD163, the
cellular receptor for PRRSV. The lipid-modiﬁcation of GP4 contributes
to PRRSV infectivity, suggesting an important role of GPI for PRRSV
entry and infection. The DAF/4-M162* mutant was lethal for infectiv-
ity, which is probably due to the inability of GP4 to anchor to the
membrane, and thus unable to associate with the lipid rafts, support-
ing the notion that the lipid rafts play an important role for PRRSV
infection.
Co-localization of GP4 and CD163 in the lipid rafts may mediate the
entry of PRRSV. Compared to peptide-anchored GP4, lipid-anchored
GP4 is likely to have the priority to locate in lipid rafts where it binds
Fig. 8. Co-localization of PRRSVGP4 and theDAF (CD55) protein as a lipid raftmarker on the plasmamembrane of HeLa cell. Cellswere transfectedwith pXJ41-Flag-GP4 (D through F) and at
24 h post-transfection,washedwith ice-cold PBS. Cells were then co-stainedwith DAF-speciﬁcMAb EVR1 (anti-CD55; A and D) and rabbit anti-Flag antibody (B and E), followed by staining
withAlexa Fluor 488®conjugated goat anti-mouse IgG(H+L) andAlexa Fluor 594®conjugated goat anti-rabbit IgG (H+L) secondary antibodies, respectively. Imageswere visualized using
a laser-scanning confocal ﬂuorescence microscope (model BX50, Olympus). Panels G through I represent the enlargement of the indicated areas in panels D through F, respectively.
27Y. Du et al. / Virology 424 (2012) 18–32to CD163 to promote the entry of PRRSV. This may explain why certain
mutations affecting the ability of lipid-anchor formation of GP4 on the
cell membrane affected the titers and growth of PRRSV as seen in otherFig. 9. Establishment of Dulac-CD163 porcine kidney cells as a cell line stably expressing po
was extracted and treated with DNase I (1 unit/μg of RNA) and PCR was performed after R
CD163, porcine CD163 gene transformed cells. Lane 2, CD163 positive control. (B) Wester
by 7.5% SDS-PAGE, followed by blotting to the PVDF membrane and probing with porcin
cells for PRRSV. Expression of porcine CD163 rendered non-permissive Dulac cells permis
was observed by ﬂuorescent microscopy (panel d). PRRSV-speciﬁc cytopathic effect was alsstudies (Metzner et al., 2008). Taken together, we have shown here
that the PRRSV GP4 protein is a GPI-modiﬁed membrane-associated
protein. Co-localization of GP4 with CD163 in the lipid rafts on thercine CD163. (A) RT-PCR for porcine CD163 mRNA in Dulac-CD163. Total cellular RNA
T (lanes 4 and 6) or without RT (lanes 3 and 5) reactions. Dulac, parental cells; Dulac-
n blot for porcine CD163. Cell lysates were prepared from Dulac-CD163 and resolved
e CD163-speciﬁc MAb. (C) Immunoﬂuorescence. (D) Permissiveness of Dulac-CD163
sive for PRRSV infection. Cells were infected with PRRSV-GFP and the GFP expression
o evident in Dulac-CD163 cells (panel c).
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Fig. 10. Co-localization of PRRSV GP4 with porcine CD163 in Dulac-CD163 cell. Parental Dulac (panels A through C) or Dulac-CD163 (panels D through F) cells were transfected with
pXJ41-Flag-GP4 and at 24 hpt, washed with ice-cold PBS. Cells were then incubated with CD163 MAb (A and D) and rabbit anti-Flag antibody (B and E), followed by staining with
Alexa Fluor 488® conjugated goat anti-mouse IgG (H+L) and Alexa Fluor 594® conjugated goat anti-rabbit IgG (H+L) secondary antibodies, respectively. Staining images were
observed under the laser-scanning confocal ﬂuorescence microscope (model BX50, Olympus). Panels G through I represent the enlarged images of the selected areas in panels D
through F, respectively.
28 Y. Du et al. / Virology 424 (2012) 18–32cell membrane implicates an important role of the complex for PRRSV
entry and infection. These ﬁndings deepen our understanding on GP4
and establish the cholesterol and lipid rafts as potential targets in the
development of control measures against PRRSV infection.
Materials and methods
Cells and viruses
MARC-145 cells (a subline of MA-104 African green monkey kidney
cells; Kim et al., 1993) were maintained as described elsewhere (Lee et
al., 2005). Porcine alveolar macrophages (PAMs) were kindly provided
by Dr. F. Zuckermann (University of Illinois at Urbana-Champaign,
Urbana, IL) and grown inRPMI-1640 (Invitrogen, Carlsbad, CA) contain-
ing 10% fetal bovine serum (FBS; HyClone, Logan, UT). HeLa and HEK-
293 cells (NIH AIDS Research and Reference Reagent Program, German-
town, MD) were grown in Dulbecco's modiﬁed Eagle medium (DMEM)
supplemented with 10% FBS. Dulac porcine kidney cells (obtained from
Dr. L. Babiuk, Vaccines and Infectious Disease Organization, Saskatoon,
Canada) were free of porcine circovirus type 1 and grown in modiﬁed
Eagle's medium (MEM) supplemented with 10% FBS. Stocks of PRRSV
(North American genotype strain PA8; Wootton et al., 2000) were pre-
pared in MARC-145 cells. PRRSV P129-GFP expressing GFP is described
elsewhere (Pei et al., 2009).
Virus titration and one-step growth kinetics
Culture supernatants harvested at 5 days post-transfection with
PRRSV infectious clones were designated ‘passage-1’. The ‘passage-1’ virus was used to inoculate fresh MARC-145 cells, and the 5-day
harvest was designated ‘passage-2’. The ‘passage-3’ virus was pre-
pared in the same way as for ‘passage-2’. Each passage virus was ali-
quoted and stored at −80 °C until use. Virus titers of ‘passage-2’
and ‘passage-3’ were determined in MARC-145 cells by a microtitra-
tion infectivity assay and recorded as 50% tissue culture infectious
dose per ml (TCID50/ml). To determine the growth kinetics of the
mutant viruses, MARC-145 cells were infected in duplicate with
‘passage-2’ virus at a multiplication of infection (MOI) of 5 and in-
cubated for indicated times. Culture supernatants were collected
and titrated by a microtitration infectivity assay and recorded as
TCID50/ml.
Antibodies, enzymes, and chemicals
Monoclonal antibody (MAb) against human DAF (clone 1G3 anti-
DAF [aa:35–135]), anti-FLAG MAb (clone M2), and anti-FLAG rabbit
antibody were from Sigma-Aldrich (St. Louis, MO); anti-GFP rabbit
antibody from Cell Signaling Technology (Danvers, MA); β-actin
MAb (AC-15) from Santa Cruz Biotechnology (Santa Cruz, CA); and
anti-porcine CD163 MAb (clone 2A100/11) from AbD Serotec (Raleigh,
NC). Tissue culture supernatant containing MAb EVR1 raised against
human DAF was kindly provided by K. Dimmock (University of Ottawa,
Ottawa, Canada) and described elsewhere (Karnauchow et al., 1996).
Alexa Fluor 488®-conjugated goat anti-mouse IgG (H+L), Alexa Fluor
594®-conjugated goat anti-rabbit IgG (H+L), and G418 (neomycin
sulfate analog) were purchased from Invitrogen (Carlsbad, CA). Horse-
radish peroxidase (HRP) conjugated-goat anti-mouse IgG and -goat
anti-rabbit IgG were purchased from Jackson ImmunoResearch
29Y. Du et al. / Virology 424 (2012) 18–32Laboratories (West Grove, PA). Phosphatidylinositol-speciﬁc phospho-
lipase C (PI-PLC) of Bacillus cereus, methyl-β-cyclodextrin (MβCD),
and water soluble cholesterol were purchased from Sigma-Aldrich.
Genes and plasmids
The eukaryotic expression vector pXJ41 is a derivative of pXJ40 in
which the polylinker region was modiﬁed (Xiao et al., 1991). The
plasmid pEGFP-N contains the PRRSV N gene fused to EGFP
(Rowland and Yoo, 2003). The PRRSV infectious cDNA clone pCMV-
S-P129 is described elsewhere (Lee et al., 2005; Lee and Yoo, 2006).
To construct pEGFP-GP4, PRRSV GP4 gene was PCR-ampliﬁed from
pCMV-S-P129 using the GP4-GFP-Fwd and GP4-GFP-Rev primer pair
(Table 1) and inserted into EcoRI and BamHI sites in pEGFP-N1 (Clon-
tech; Mountain View, CA). To generate pXJ41-FLAG-GP4, the FLAG-
tag sequence (YKDDDDKGS) was inserted between nucleotide posi-
tions 261 and 262 (corresponding amino acid positions D87 and
E88, respectively) of GP4 by three-point ligations of PCR products
generated using the primer pairs, FLAG-GP4-A and -B, and FLAG-
GP4-C and -D (Table 1) at EcoRI, BamHI, and HindIII sites (Fig. 1F).
The human DAF gene was ampliﬁed from plasmid pEF6/V5-DAF (pro-
vided by K. Dimmock, University of Ottawa, Ottawa, Canada) using
DAF-Fwd and DAF-Rev primers (Table 1). The PCR product was
digested with EcoRI and BamHI followed by cloning into pXJ41 to
generate pXJ41-DAF. pXJ41-DAF/4 was created by overlapping exten-
sion PCR (Horton et al., 1989). Brieﬂy, the region representing amino
acid positions 1–348 of human DAF was ampliﬁed from pEF6/V5-DAF
using DAF-Fwd and DAF/4-B primers. The C-terminal region of GP4
(GP4-C, positions 144–179; Fig. 1) was ampliﬁed from plasmid
pCMV-S-P129 using primers DAF/4-C and DAF/4-D (Table 1). Then,
overlapping extension PCR was conducted using the PCR products
of DAF (1–348 aa) and GP4-C (144–179 aa) as templates and primers
DAF-Fwd and DAF/4-D (Table 1). The DAF/4 fusion gene (1–348 aa
fragment of DAF and GP4-C fragment) was inserted at EcoRI and
BamHI sites in pXJ41 to generate pXJ41-DAF/4 (Fig. 3). Plasmid
pXJ41-DAF/2 was constructed in a similar way using GP2-C repre-
senting 204–256 aa of GP2 (Fig. 3). The primer sequences are listed
in Table 1.
GPI anchor prediction and site-directed mutagenesis
The topology of GP4 (http://mobyle.pasteur.fr/cgi-bin/portal.py?
#forms::toppred; Claros and von Heijne, 1994) and the GPI anchorTable 1
Primers used in construction and mutagenesis studies.
Primer name Sequence (5′-3′)
GP4-GFP-Fwd GAGGAATTCCACCATGGCTGCGTCCCTTC
GP4-GFP-Rev TATGGATCCCGACCGCCACCGCCACCAATTGCCA
Flag-GP4-A GAGGAATTCCACCATGGCTGCGTCCCTTC
Flag-GP4-B GCGGGATCCCTTATCGTCGTCATCCTTGTAATCT
Flag-GP4-C GAGGGATCCGAGAATTACTTACA
Flag-GP4-D GAGAAGCTTATCAAATTGCCAGTAGGA
DAF-Fwd GTCGAATTCCACCATGGCAACCGTCGCGCGGCC
DAF-Rev GAGGGATCCTTACTAAGTCAGCAAGCCC
DAF/4-B CGACCACCAAGGAGCGTCCTTTATTTGGGGTTG
DAF/4-C AAACAACCCCAAATAAAGGACGCTCCTTGGTGG
DAF/4-D GAGGGATCCTTATCAAATTGCCACCAGAATGG
DAF/2-B AGCCATTGCTGAAAATCATGTCCTTTATTTGGGG
DAF/2-C AAACAACCCCAAATAAAGGACATGATTTTCAGC
DAF/2-D GAGGGATCCTTATCACCATGAGTTCGAAA
DAF/4-157-F GCGGCTGCTTCATTTCGTCACACCTGAGACCATG
DAF/4-157-R TCATGGTCTCAGGTGTGACGAAATGAAGCAGCC
DAF/4-162-F CATGACACCTGAGACCGTCAGGTGGGCAACCGT
DAF/4-162-R AACGGTTGCCCACCTGACGGTCTCAGGTGTCAT
DAF/4-162S-F CATGACACCTGAGACCTAGAGGTGGGCAACCGT
DAF/4-162S-R AACGGTTGCCCACCTCTAGGTCTCAGGTGTCATG
Restriction enzyme recognition sites are indicated in boldface italics. Mutagenized codons aattachment signal (http://gpi.unibe.ch; Fankhauser and Mäser,
2005; Eisenhaber et al., 1998) were predicted using on-line programs
available on the Bioinformatics Resource Portal (http://expasy.org/
tool). Speciﬁc mutations were introduced to plasmids pXJ41-DAF/4
and pCMV-S-P129 using the QuikChange XL site-directed mutagene-
sis kit (Stratagene, La Jolla, CA) with modiﬁcations as described else-
where (Du et al., 2010).
Transfection
Plasmid DNA transfection was carried out using Lipofectamine™
2000 according to the manufacturer's instruction (Invitrogen,
Carlsbad, CA). HeLa cells were seeded in 35-mm diameter dishes and
grown to 70% conﬂuency and transfected with 2 μg of DNA diluted in
Opti-MEM (Invitrogen, Carlsbad, CA). After 4 h incubation, transfection
medium was replaced with DMEM supplemented with 10% FBS. At
24 h post-transfection (hpt), cells were washed with PBS and lysed in
the buffer (20 mM Tris–HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA,
1 mM EGTA, 1% TritonX-100, 1% NP-40 and 1 mM PMSF) for western
blot analysis. For transfection of pXJ41-DAF, pXJ41-DAF/2, pXJ41-DAF/
4, and their mutant derivatives, HEK-293 cells grown in 60-mm diam-
eter dishes were transfected using 10 μl Lipofectamine 2000 and 4 μg
individual plasmid in 2 ml Opti-MEM. After 6 h incubation, the trans-
fection mix was replaced with DMEM supplemented with 10% FBS. At
24 hpt, cells were washed once with PBS and trypsinized for PI-PLC di-
gestion and FACS analysis. For transfection of PRRSV infectious clone
pCMV-S-P129 and its derivatives, MARC-145 cells grown in 35-mm di-
ameter dishes were used.MARC-145 cells were transfectedwith 2 μg of
an infectious clone using Lipofectamine 2000 as described above.
Transfected cells were incubated at 37 °C for 5 days in DMEM supple-
mented with 5% FBS prior to collection of supernatant for virus
recovery.
PI-PLC digestion
HeLa cells or HEK-293 cells were transfected with pXJ41-DAF,
pXJ41-DAF/2, pXJ41-DAF/4 or their derivatives and incubated for
1 day. Cells were washed with PBS, trypsinized, and collected by cen-
trifugation at 2000 rpm for 10 min (Eppendorf 5415R). Then, the cells
were washed twice using PI-PLC buffer (10 mM Tris–HCl [pH 7.4],
144 mM NaCl, 0.05% bovine serum albumin [BSA]) and resuspended
in PI-PLC buffer. Cells were divided into two equal fractions: one for
PI-PLC treatment (1.5 U/ml; Sigma-Aldrich) and another as a controlPurpose
GP4 ampliﬁcation
GTAGGA GP4 ampliﬁcation
Flag-GP4 ﬁrst segment ampliﬁcation
GTCACATTGGC Flag-GP4 ﬁrst segment ampliﬁcation
Flag-GP4 second segment ampliﬁcation
Flag-GP4 second segment ampliﬁcation
DAF, DAF/4 and DAF/2 ampliﬁcation
DAF ampliﬁcation
TTT DAF/4 ﬁrst segment ampliﬁcation
TCG DAF/4 second segment ampliﬁcation
DAF/4 second segment ampliﬁcation
TTGTTT DAF/2 ﬁrst segment ampliﬁcation
AATGGCT DAF/2 second segment ampliﬁcation
DAF/2 second segment ampliﬁcation
A DAF/4-M157Vmutation
GC DAF/4-M157V mutation
T DAF/4-M162V mutation
G DAF/4-M162V mutation
T DAF/4-M162S mutation
DAF/4-M162Smutation
re underlined in boldface.
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PLC, both fractions of cells were centrifuged at 2000 rpm for 10 min
(Eppendorf 5415R). The supernatants were subjected to western blot
analysis whereas the cell pellets were washed twice in ice-cold FACS
buffer (1.0% BSA, 0.01% sodium azide in PBS) followed by ﬂuorescein-
activated cell sorter (FACS) analysis.
FACS
PI-PLC-treated or untreated cells were stained with DAF-speciﬁc
MAb EVR1 at 4 °C for 30 min. Cells were washed twice in ice-cold
FACS buffer and ﬁxed with 4% paraformaldehyde in PBS (pH 7.4) for
1 h at 4 °C. After wash with FACS buffer, cells were incubated with
Alexa Fluor 488®-conjugated goat anti-mouse IgG (H+L) secondary
antibody for 1 h, washed twice with FACS buffer, and resuspended in
1% paraformaldehyde in PBS (pH 7.4) for ﬂow cytometry (BD Biosci-
ences LSR II Analyzer). The data were analyzed using the FACS Express
software (Ver. 3 Research Edition, De Novo Software; Los Angeles, CA).
Western blot analysis
The supernatants obtained from PI-PLC digested cells were centri-
fuged to remove cell debris at 13,000 rpm for 20 min in a microcentri-
fuge (Eppendorf 5415R). The supernatants were collected and boiled
in SDS-PAGE loading buffer (60 mM Tris–HCl [PH 6.8], 2% SDS, 0.1%
bromophenol blue, 25% glycerol, 5% β-mercapto ethanol) for 5 min,
followed by 10% SDS-PAGE and transfer to polyvinylidenediﬂuoride
(PVDF) membranes (Millipore). The membranes were blocked with
5% non-fat dry milk in TBST (10 mM Tris–HCl [PH8.0], 150 mM NaCl,
0.1% Tween 20) for 4 h at room temperature (RT) and incubated with
rabbit anti-GFP antibody, anti-FLAG MAb, or anti-DAF MAb overnight
at 4 °C. After 5 washes for 10 min each with TBST, the membranes
were incubated with HRP-conjugated goat anti-rabbit or goat anti-
mouse IgG for 1 h,washedﬁve times for 10 min eachwith TBST, and de-
veloped using Supersignal® West Pico Chemiluminescent Substrate
according to the manufacturer's instruction (Pierce, Rockford, IL).
Fluorescent microscopy
Cells resuspended in 1% paraformaldehyde in PBS for FACS analy-
sis were spotted on microscope slides and visualized using a ﬂuores-
cent microscope (Olympus, model AX70). Dulac-CD163 cells infected
with PRRSV P129-GFP were also examined directly by ﬂuorescent
microscopy.
Cholesterol depletion, replenishment, and PRRSV infectivity assays
Cell cytotoxicity of MβCD was determined for both MARC-145
cells and PAMs in 96-well plates at concentrations of 0, 0.25,0.5, 1,
2, 5, 10, and 20 mM. Ten millimolar or higher concentration of
MβCD was found to be toxic for MARC-145 cells and PAMs, and
thus 0.25–2 mM concentrations were chosen for subsequent studies.
MARC-145 cells and PAMs were treated with variable concentrations
of MβCD for 1 h at 37 °C and infected with PRRSV PA8 at a MOI of 5.
After 1 h incubation, cells were washed twice and cultivated in
DMEM or RPMI-1640 supplemented with 2% FBS. For cholesterol re-
plenishment, cells were pretreated with 2 mM MβCD for 1 h at
37 °C and then supplemented with variable concentrations of water
soluble cholesterol for 1 h at 37 °C (Popik et al., 2002). After two
washes with DMEM for MARC-145 cells or RPMI-1640 for PAMs, the
cells were infected with PRRSV as above. MARC-145 cells and PAMs
were incubated for 3 days and 20 h, respectively, and the culture
supernatants were collected and titrated in MARC-145 cells as
described above.Establishment of a stable cell line expressing CD163
Dulac cells were transfected with pcDNA-CD163 which contained
the porcine CD163 gene, and selected for neomycin resistance using
1 mg/ml of G418 in the culture medium. G418-resistant cell colonies
were picked using cloning cylinders and ampliﬁed for screening as
described elsewhere (Lee et al., 2004). The gene expression was con-
ﬁrmed by PCR, RT-PCR, and protein assays by FA and western blot,
and the cells expressing porcine CD163 were designated Dulac-
CD163.
Immunoﬂuorescence and confocal microscopy
HeLa, Dulac, and Dulac-CD163 cells were plated on microscope
cover slips and transfected with pXJ41-FLAG-GP4. At 24 hpt, cells
were washed once with ice-cold PBS and incubated with respective
primary antibodies at 4 °C for 30 min as follows: DAF-speciﬁc MAb
EVR1 and anti-FLAG rabbit antibody for HeLa cells transfected with
pXJ41-FLAG-GP4; CD163-speciﬁc MAb and anti-FLAG rabbit antibody
for Dulac-CD163 cells transfected with pXJ41-Flag-GP4. Cells were
washed twice in ice-cold PBS and ﬁxed with 4% paraformaldehyde
in PBS at 4 °C for 1 h. Cells were then washed again three times
with ice-cold PBS and incubated with Alexa Fluor 488®-conjugated
goat anti-mouse IgG (H+L) or Alexa Fluor 594®-conjugated goat
anti-rabbit IgG (H+L) antibodies. The coverslips were washed ﬁve
times in PBS, mounted on microscope slides in mounting buffer
(60% glycerol and 0.1% sodium azide in PBS), and visualized under a
laser-scanning confocal ﬂuorescence microscope (model BX50,
Olympus).
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